- Anxiety
- Depression
- Alzheimer's Disease
- Weight Loss
- Heart Disease
- Cancer
- Asthma
Trial Phase
Trial Status
Paid Participation
Clear All
59 Blockage Trials Near You
Power is an online platform that helps thousands of Blockage patients discover FDA-reviewed trials every day. Every trial we feature meets safety and ethical standards, giving patients an easy way to discover promising new treatments in the research stage.
Learn More About PowerLimFlow System for Critical Limb Ischemia
Trial Details
Key Eligibility Criteria
105 Participants Needed
Virtual Cardiac Rehab Program for Heart Disease
Trial Details
Key Eligibility Criteria
259 Participants Needed
Sirolimus Coated Balloon for Peripheral Arterial Disease
Trial Details
Key Eligibility Criteria
368 Participants Needed
Non-Invasive Retinal Assessment for Retinal Disease
Trial Details
Key Eligibility Criteria
500 Participants Needed
Nerve Block for Jaw Pain
Trial Details
Key Eligibility Criteria
20 Participants Needed
Balloon Inflation Techniques for Coronary Artery Disease
Trial Details
Key Eligibility Criteria
40 Participants Needed
Microwave Ablation for Airway Blockage
Trial Details
Key Eligibility Criteria
10 Participants Needed
High Flow Nasal Cannula for COPD
Trial Details
Key Eligibility Criteria
40 Participants Needed
Embolization for Rotator Cuff Injury
Trial Details
Key Eligibility Criteria
41 Participants Needed
Portable Dynamic Chest X-Ray for ICU Patients
Trial Details
Key Eligibility Criteria
230 Participants Needed
Trial Details
Key Eligibility Criteria
50 Participants Needed
LifeVac, Dechoker, and Abdominal Thrusts for Choking
Trial Details
Key Eligibility Criteria
132 Participants Needed
SILQ ClearTract Catheter for Chronic Urinary Retention
Trial Details
Key Eligibility Criteria
200 Participants Needed
Statseal vs. Perclose for Cardiovascular Procedures
Trial Details
Key Eligibility Criteria
150 Participants Needed
Catheter Locking Solution for Catheter Complications
Trial Details
Key Eligibility Criteria
1524 Participants Needed
Genicular Artery Embolization for Knee Osteoarthritis
Trial Details
Key Eligibility Criteria
30 Participants Needed
Trial Details
Key Eligibility Criteria
225 Participants Needed
Ianalumab + Eltrombopag for Low Platelet Count
Trial Details
Key Eligibility Criteria
152 Participants Needed
Ianalumab for Autoimmune Hemolytic Anemia
Trial Details
Key Eligibility Criteria
90 Participants Needed
Nerve Block Timing for Shoulder Pain
Trial Details
Key Eligibility Criteria
79 Participants Needed
Why Other Patients Applied
"I've tried several different SSRIs over the past 23 years with no luck. Some of these new treatments seem interesting... haven't tried anything like them before. I really hope that one could work."
"I was diagnosed with stage 4 pancreatic cancer three months ago, metastatic to my liver, and I have been receiving and responding well to chemotherapy. My blood work revealed that my tumor markers have gone from 2600 in the beginning to 173 as of now, even with the delay in treatment, they are not going up. CT Scans reveal they have been shrinking as well. However, chemo is seriously deteriorating my body. I have 4 more treatments to go in this 12 treatment cycle. I am just interested in learning about my other options, if any are available to me."
"I've been struggling with ADHD and anxiety since I was 9 years old. I'm currently 30. I really don't like how numb the medications make me feel. And especially now, that I've lost my grandma and my aunt 8 days apart, my anxiety has been even worse. So I'm trying to find something new."
"I have dealt with voice and vocal fold issues related to paralysis for over 12 years. This problem has negatively impacted virtually every facet of my life. I am an otherwise healthy 48 year old married father of 3 living. My youngest daughter is 12 and has never heard my real voice. I am now having breathing issues related to the paralysis as well as trouble swallowing some liquids. In my research I have seen some recent trials focused on helping people like me."
"My orthopedist recommended a half replacement of my right knee. I have had both hips replaced. Currently have arthritis in knee, shoulder, and thumb. I want to avoid surgery, and I'm open-minded about trying a trial before using surgery as a last resort."
Sugammadex vs Neostigmine for Neuromuscular Blockade
Trial Details
Key Eligibility Criteria
80 Participants Needed
Reversal Agents for Postoperative Urinary Retention
Trial Details
Key Eligibility Criteria
286 Participants Needed
Regorafenib + Pembrolizumab for Colorectal Cancer
Trial Details
Key Eligibility Criteria
154 Participants Needed
Allopregnanolone for PTSD
Trial Details
Key Eligibility Criteria
256 Participants Needed
Lorigerlimab for Advanced Solid Tumors
Trial Details
Key Eligibility Criteria
162 Participants Needed
rHSC-DIPGVax + Checkpoint Inhibitors for Brain Tumor
Trial Details
Key Eligibility Criteria
36 Participants Needed
Trial Details
Key Eligibility Criteria
60 Participants Needed
Avelumab for Thymic Cancer
Trial Details
Key Eligibility Criteria
60 Participants Needed
Ipilimumab + Nivolumab for Colorectal Cancer
Trial Details
Key Eligibility Criteria
65 Participants Needed
Combination Therapy + TACE for Liver Cancer
Trial Details
Key Eligibility Criteria
27 Participants Needed
Know someone looking for new options?
Spread the word
Learn More About Power
We started Power when my dad was diagnosed with multiple myeloma, and I struggled to help him access the latest immunotherapy. Hopefully Power makes it simpler for you to explore promising new treatments, during what is probably a difficult time.
Frequently Asked Questions
How much do Blockage clinical trials pay?
Each trial will compensate patients a different amount, but $50-100 for each visit is a fairly common range for Phase 2–4 trials (Phase 1 trials often pay substantially more). Further, most trials will cover the costs of a travel to-and-from the clinic.
How do Blockage clinical trials work?
After a researcher reviews your profile, they may choose to invite you in to a screening appointment, where they'll determine if you meet 100% of the eligibility requirements. If you do, you'll be sorted into one of the treatment groups, and receive your study drug. For some trials, there is a chance you'll receive a placebo. Across Blockage trials 30% of clinical trials have a placebo. Typically, you'll be required to check-in with the clinic every month or so. The average trial length for Blockage is 12 months.
How do I participate in a study as a "healthy volunteer"?
Not all studies recruit healthy volunteers: usually, Phase 1 studies do. Participating as a healthy volunteer means you will go to a research facility several times over a few days or weeks to receive a dose of either the test treatment or a "placebo," which is a harmless substance that helps researchers compare results. You will have routine tests during these visits, and you'll be compensated for your time and travel, with the number of appointments and details varying by study.
What does the "phase" of a clinical trial mean?
The phase of a trial reveals what stage the drug is in to get approval for a specific condition. Phase 1 trials are the trials to collect safety data in humans. Phase 2 trials are those where the drug has some data showing safety in humans, but where further human data is needed on drug effectiveness. Phase 3 trials are in the final step before approval. The drug already has data showing both safety and effectiveness. As a general rule, Phase 3 trials are more promising than Phase 2, and Phase 2 trials are more promising than phase 1.
Do I need to be insured to participate in a Blockage medical study?
Clinical trials are almost always free to participants, and so do not require insurance. The only exception here are trials focused on cancer, because only a small part of the typical treatment plan is actually experimental. For these cancer trials, participants typically need insurance to cover all the non-experimental components.
What are the newest Blockage clinical trials?
Most recently, we added Balloon Inflation Techniques for Coronary Artery Disease, Siltuximab for Rejection and Ipilimumab + Nivolumab for Colorectal Cancer to the Power online platform.